Our recent studies demonstrated that inhibition of EZH2, the enzymatic unit of PRC2, protects against kidney damage in murine models of AKI induced by ischemia/reperfusion and folic acid21, 22; we thus assumed that inhibition of PRC2 catalytic activity by targeting EED would also protect against AKI. Here, EZH2 is linked to acute kidney injury.